ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study

Jiang, Yuming; Zhang, Zhicheng; Yuan, Qingyu; Wang, Wei; Wang, Hongyu; Li, Tuanjie; Huang, Weicai; Xie, Jingjing; Chen, Chuanli; Sun, Zepang; Yu, Jiang; Xu, Yikai; Poultsides, George A.; Xing, Lei; Zhou, Zhiwei*; Li, Guoxin*; Li, Ruijiang*南方医科大学; 西北工业大学; 中山大学; 1
Lancet Digital Health2022-5
32被引12阅读
引用收藏
分享

摘要

Background Peritoneal recurrence is the predominant pattern of relapse after curative-intent surgery for gastric cancer and portends a dismal prognosis. Accurate individualised prediction of peritoneal recurrence is crucial to identify patients who might benefit from intensive treatment. We aimed to develop predictive models for peritoneal recurrence and prognosis in gastric cancer. @@@ Methods In this retrospective multi-institution study of 2320 patients, we developed a multitask deep learning model for the simultaneous prediction of peritoneal recurrence and disease-free survival using preoperative CT images. Patients in the training cohort (n=510) and the internal validation cohort (n=767) were recruited from Southern Medical University Guangzhou, China. Patients in the external validation cohort (n=1043) were recruited from Sun Yat-sen University Cancer Center, Guangzhou, China. We evaluated the prognostic accuracy of the model as well as its association with chemotherapy response. Furthermore, we assessed whether the model could improve the ability of clinicians to predict peritoneal recurrence. @@@ Findings The deep learning model had a consistently high accuracy in predicting peritoneal recurrence in the training cohort (area under the receiver operating characteristic curve [AUC] 0.857; 95% CI 0.826-0. 889), internal validation cohort (0.856; 0.829-0-882), and external validation cohort (0.843; 0.819-0.866). When informed by the artificial intelligence (AI) model, the sensitivity and inter-rater agreement of oncologists for predicting peritoneal recurrence was improved. The model was able to predict disease-free survival in the training cohort (C-index 0.654; 95% CI 0. 616-0.691), internal validation cohort (0.668; 0.643-0.693), and external validation cohort (0.610; 0.583-0.636). In multivariable analysis, the model predicted peritoneal recurrence and disease-free survival independently of clinicopathological variables (p<0.0001 for all). For patients with a predicted high risk of peritoneal recurrence and low survival, adjuvant chemotherapy was associated with improved disease-free survival in both stage II disease (hazard ratio [HR] 0.543 [95% CI 0.362-0.815]; p=0.003) and stage III disease (0.531 [0.432-0.652]; p<0.0001). By contrast, chemotherapy had no impact on disease-free survival for patients with a predicted low risk of peritoneal recurrence and high survival. For the remaining patients, the benefit of chemotherapy depended on stage: only those with stage III disease derived benefit from chemotherapy (HR 0.637 [95% CI 0.484-0.838]; p=0.001). @@@ Interpretation The deep learning model could allow accurate prediction of peritoneal recurrence and survival in patients with gastric cancer. Prospective studies are required to test the clinical utility of this model in guiding personalised treatment in combination with clinicopathological criteria.

学科与关键词

关键词
CHEMOTHERAPYGASTRECTOMYADENOCARCINOMACARCINOMATOSISSURGERYMODEL
相关
加载中…
  • Noninvasive Prediction of Occult Peritoneal Metastasis in Gastric Cancer Using Deep Learning
    Jiang, Yuming; Liang, Xiaokun; Wang, Wei; Chen, Chuanli; Yuan, Qingyu; Zhang, Xiaodong; Li, Na; Chen, Hao; Yu, Jiang; Xie, Yaoqin; Xu, Yikai; Zhou, Zhiwei; Li, Guoxin*; Li, Ruijiang*JAMA Network Open, 2021, 4(1): e2032269.被引 49
  • Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer
    Jiang, Yuming; Jin, Cheng; Yu, Heng; Wu, Jia; Chen, Chuanli; Yuan, Qingyu; Huang, Weicai; Hu, Yanfeng; Xu, Yikai; Zhou, Zhiwei*; Fisher, George A., Jr.; Li, Guoxin*; Li, Ruijiang*Annals of Surgery, 2021, 274(6): E1153-E1161.被引 108
  • Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study
    Sun, Zepang; Wang, Wei; Huang, Weicai; Zhang, Taojun; Chen, Chuanli; Yuan, Qingyu; Chen, Yan; Zhou, Kangneng; Han, Zhen; Feng, Hao; Chen, Hao; Liang, Xiaokun; Hu, Yanfeng; Yu, Jiang; Liu, Hao; Yu, Lequan; Xu, Yikai*; Li, Guoxin*; Jiang, Yuming*International Journal of Surgery, 2023, 109(7): 2010-2024.
查看全部 →

发表信息

论文状态
公开发表
期刊
Lancet Digital Health
发表日期
2022-05
卷期
第 4 卷, 第 5 期
页码
E340-E350
期刊等级
1区
成果收录
SCIE
资助标注
US National Institutes of Health [R01 CA222512, R01 CA233578]; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer [2020B121201004]; Guangdong Provincial Major Talents Project [2019JC05Y361]

作者

  • J

    Jiang, Yuming (第一作者)

  • Z

    Zhang, Zhicheng

查看全部 17 位作者收起作者
  • Y

    Yuan, Qingyu

    southern med univ

  • W

    Wang, Wei

    sun yat sen univ

  • W

    Wang, Hongyu

    northwestern polytech univ

  • L

    Li, Tuanjie

    1 · southern med univ

  • H

    Huang, Weicai

    1 · southern med univ

  • X

    Xie, Jingjing

  • C

    Chen, Chuanli

    southern med univ

  • S

    Sun, Zepang

    1 · southern med univ

  • Y

    Yu, Jiang

  • X

    Xu, Yikai

    southern med univ

  • P

    Poultsides, George A.

  • X

    Xing, Lei

  • Z

    Zhou, Zhiwei (通讯)

    sun yat sen univ

  • L

    Li, Guoxin (通讯)

    1 · southern med univ

  • L

    Li, Ruijiang (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417